PURE Bioscience, Inc. (PURE)

PURE Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	8	9	18	37	118	24
Market Cap Growth	-33.87%	-45.89%	-52.20%	-68.86%	396.32%	-37.24%
Enterprise Value	9	9	14	34	114	23
PE Ratio	-	-2.39	-5.00	-15.79	-19593.26	-3.61
PS Ratio	3.64	5.04	9.44	9.32	17.00	12.41
PB Ratio	-4.12	34.81	4.48	10.99	24.44	19.90
P/FCF Ratio	-3.35	-2.86	-7.00	-21.69	192.41	-7.89
P/OCF Ratio	-3.29	-2.89	-7.24	-31.37	175.72	-7.92
EV/Sales Ratio	4.54	5.01	7.61	8.78	16.44	12.20
EV/EBITDA Ratio	-3.48	-2.67	-4.39	-16.08	565.77	-4.36
EV/EBIT Ratio	-3.35	-2.59	-4.12	-14.89	12635.62	-4.17
EV/FCF Ratio	-4.06	-2.84	-5.65	-20.42	186.12	-7.75
Debt / Equity Ratio	-1.12	3.75	0	0.07	0	0
Debt / EBITDA Ratio	-0.78	-0.29	-	-0.11	-	-
Debt / FCF Ratio	-0.91	-0.31	-	-0.14	-	-
Quick Ratio	1.13	2.59	6.25	2.84	3.26	1.04
Current Ratio	1.30	3.02	6.72	3.30	3.68	1.41
Asset Turnover	1.43	1.03	0.41	0.91	1.09	0.99
Interest Coverage	-19.93	-281.64	-570.83	-577.75	1.80	-931.50
Return on Equity (ROE)	168.97%	-1456.25%	-89.46%	-69.58%	-0.12%	-551.34%
Return on Assets (ROA)	-394.13%	-217.04%	-77.99%	-53.89%	-0.09%	-339.60%
Return on Capital (ROIC)	-1384.25%	-304.95%	-87.62%	-64.70%	-0.28%	-469.66%
Earnings Yield	-47.67%	-41.83%	-19.98%	-6.33%	-0.01%	-27.70%
FCF Yield	-34.70%	-34.97%	-14.28%	-4.61%	0.52%	-12.68%
Buyback Yield / Dilution	-0.45%	-25.41%	-1.91%	-3.03%	-16.10%	-8.33%
Total Shareholder Return	-0.45%	-25.41%	-1.91%	-3.03%	-16.10%	-8.33%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.